This opinion piece discusses the issues with identification and management of depression in brain tumor patients and recommends best practice within the field.
This review explores the link between neurological disorders and depressive illnesses. In particular, focussing on the use of inflammatory factors as predictive biomarkers of neuropsychiatric disorders.
New research has shown that ADHD children and their mothers are more likely to have shorter telomeres, potentially increasing their risk of diseases and disorders such as cancer, diabetes and obesity.
A novel gene-expression study focusing on neurotransmitter regulation in depression offers possible explanation for gender disparities in suicide rates and reveals potential new targets for antidepressant drugs.
Preclinical findings have identified novel compounds – GABA-NAMs – that are able to reduce inhibitory communication in the brain and may hold the potential to rapidly treat depression
This review explores pharmacogenetics role in the safety and efficacy of electroconvulsive therapy for patients with psychiatric disorders.
Researchers demonstrate that inhibiting microglial activation could be a potential strategy for restoring the disrupted dopamine transmission linked to mental health disorders, such as anxiety and depression.
A novel population health management program for older adults has achieved significant health improvement for individuals with depression and reductions in stress for caregivers of dementia patients.